ZBRA · Zebra Technologies Corporation · Stock research

Current Thesis

The leg being bought is unchanged from the 2026-08-04 repricing: a barcode-and-rugged-handheld installed base re-rated as an automation, machine-vision and "frontline AI" franchise, forced by Q2 FY26 non-GAAP EPS of $6.35 against $4.36 consensus and an FY26 EPS guide lifted from $18.30–$18.70 to $20.75–$21.25. What has changed in the two weeks since is the character of the move rather than the story. The shares printed a 52-week high at $383.06 and closed 2026-08-21 at $368.51, 3.8% under that high, with RSI(14) at 76.4 after 88.6 on 2026-08-07. The last company-specific headline was the seven-firm target reset on 2026-08-05.

The Q2 FY26 Form 10-Q, filed 2026-08-04 alongside the release, put structure on what made the quarter look easy: the $73M IEEPA tariff benefit was recognised inside Cost of Sales, split $46M to Connected Frontline and $27M to Asset Visibility & Automation, and only $14M arrived as cash — $59M sits as a receivable at the 2026-07-04 quarter end.

Bullish and bearish views on Zebra Technologies Corporation

The model's bull view on Zebra Technologies Corporation (ZBRA), in brief: Q2 FY26 (2026-08-04): net sales $1,557M, +20.4% YoY and +9.2% organic; non-GAAP EPS $6.35 vs $4.36 consensus; GAAP diluted EPS $4.85 against $2.19 a year earlier, on net income of $233M vs $112M. The bear view: The company guided its own margin down. Q2 adjusted EBITDA was $431M, 27.7% of adjusted net sales; Q3 FY26 is guided to roughly 22% and FY26 to 23.5%–24.0%. A $73M item sits in Cost of Sales, and most of it is not yet cash. The 10-Q records $59M of the IEEPA benefit as a… Both cases follow in full.

Bull Case

• Q2 FY26 (2026-08-04): net sales $1,557M, +20.4% YoY and +9.2% organic; non-GAAP EPS $6.35 vs $4.36 consensus; GAAP diluted EPS $4.85 against $2.19 a year earlier, on net income of $233M vs $112M.
• The raise was large. FY26 non-GAAP EPS $18.30–$18.70 → $20.75–$21.25; FY26 sales $5.936–$6.151B → $6.151–$6.259B.
• Q3 guided above the Street on both lines (2026-08-04): non-GAAP EPS $4.70–$4.90 vs $4.53 estimate, sales $1.544–$1.584B vs $1.504B estimate.
• Segment mix favours the automation side. Per the 10-Q for the quarter ended 2026-07-04, AVA posted $654M of sales and $192M of operating income (29.4%) against CF's $903M and $219M (24.3%); AVA grew +11.4% organic vs CF's +7.5%.
• Cash generation: H1 FY26 free cash flow $361M, FY26 FCF guided above $1B, H1 repurchases of $568M covering 2,468,021 shares.
• The sell side reset as a bloc on 2026-08-05: BNP Paribas Outperform $455, TD Cowen Buy $450, KeyBanc Overweight $430, Barclays Overweight $410, Needham Buy $410, Citi Neutral $396, Truist Hold $355. Only Truist's $355 sits below the 2026-08-21 close of $368.51.

Bear Case

• The company guided its own margin down. Q2 adjusted EBITDA was $431M, 27.7% of adjusted net sales; Q3 FY26 is guided to roughly 22% and FY26 to 23.5%–24.0%.
• A $73M item sits in Cost of Sales, and most of it is not yet cash. The 10-Q records $59M of the IEEPA benefit as a receivable, with $14M received. Collection and any comparable H2 benefit are both unresolved.
• Headline growth is heavily inorganic. Roughly 8 points of the FY26 14%–16% guide comes from acquisitions and FX; roughly 10.5 points of Q3's 17%–20%. Organic was 9.2% in Q2.
• Memory is the swing factor. Management flagged an approximately $120M FY headwind on the 2026-08-04 call, said guidance assumes full mitigation via targeted price increases, restructuring savings and volume leverage, and separately noted demand signals exceeding memory supply.
• Debt is front-loaded. $2,776M total debt against $157M cash at 2026-07-04, of which $2,275M is classified current and largely maturing in 2027 — a refinancing decision running alongside a buyback that consumed $568M in H1.

• Inventories were $733M at 2026-07-04 versus $729M at year-end 2025 — no visible build ahead of the memory cost step-up.

Setup & Price Structure

The narrative is maturing. The attention arrived and has been absorbed. The 2026-08-04 session produced a roughly 20% single-day advance, the seven-firm target reset landed 2026-08-05, and no new company headline has followed through 2026-08-21. Price marked $383.06 and has since drifted to $368.51. RSI(14) has come off 88.6 to 76.4, still above 70. The frame is intact and the numbers still support it; what has thinned is fresh incremental news flow, and there is no company-dated event for roughly ten weeks.

Structure. The whole repricing is one gap session. The 2026-08-04 guidance-raise range is the reference structure, and its floor near $330 is the level whose loss would return the shares to pre-print territory. Between the last close and that floor sits an untested post-gap consolidation — the shares have not yet built a base with more than three weeks of history, which is a small sample for judging support.

Crowding observables, stated as observables. RSI(14) 76.4 after 88.6 two weeks earlier; the shares up 44.2% over three months; two open-market insider sales inside four sessions at $375.20 and $377.68, the larger one not marked as a plan sale and cutting that officer's direct holding to 5,170 shares; six of seven post-print price targets above the last close; no earnings date inside 30 days.

Catalyst Calendar (next 30 days)

• 2026-08-22 → 2026-09-21: no company-dated event scheduled. The Q2 FY26 Form 10-Q was filed 2026-08-04 with the release, not mid-August; that item has come and gone and its contents are already in the prices above.
• 2026-11-03 (outside the window): Q3 FY26 results — the first scheduled test of the ~22% adjusted EBITDA margin guide and the $4.70–$4.90 EPS range.

Elapsed catalysts

• ~September 2026 (est.), unconfirmed: Zebra presented at four investor conferences in the May–June window announced 2026-05-14 (Wolfe 05-21, Bernstein 05-27, TD Cowen 05-28, William Blair 06-04). No equivalent autumn schedule has been announced as of 2026-08-22; a conference appearance is the only plausible in-window company communication and it is not on the calendar. (passed 4d ago)

What Would Change Our Mind

The structure that carries the thesis is the 2026-08-04 gap. If that session is retraced, the guidance raise has been repriced away and the automation re-rating no longer has a price to point at: a weekly close below $330 is the gradeable break. Short of that, the specific datapoint that would flip the read is Q3 on 2026-11-03 landing at or under the $4.70 low end of the guide with adjusted EBITDA margin beneath the ~22% frame, or a cut to the FY26 23.5%–24.0% margin guide — either would say the ~$120M memory headwind is landing in gross margin rather than in price.

A disclosure that the $59M IEEPA receivable will not be collected, or a Q4 implied guide that puts FY26 EPS at or under $20.75, would do the same work from the other direction.

What would strengthen the case instead: Q3 organic growth printing above Q2's 9.2% while the ~22% margin guide holds, the $59M receivable converting to cash, and a reclaim of $383.06 on volume — the objection today is positioning and a ten-week news vacuum, not the reported numbers.

Correlation Notes

• Memory cost cycle. The ~$120M FY headwind ties gross margin to DRAM/NAND pricing. ZBRA's margin line reacts to memory-supply headlines on a lag that has nothing to do with enterprise-software multiples.
• Direct competitor read-through. Honeywell's productivity business, Datalogic and Cognex on the machine-vision side are the check on the price-increase mitigation plan; any competitor claiming share gains in rugged mobile computing is a direct contradiction of the volume-leverage assumption inside the FY26 guide.
• Tariff policy. The $73M pretax benefit and the $59M receivable make an accrual on the balance sheet levered to IEEPA refund outcomes, so policy headlines hit a hard number here rather than sentiment alone.
• Risk-on beta. The 2026-08-04 print landed on a record-high S&P 500 session with Palantir +27%, and the week closed with US payrolls shrinking 23K in July on a market that rallied. Part of the move came from the tape, so a broad de-rating of high-momentum industrial-tech would pull ZBRA without any company news.